Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins

Journal of Autoimmunity

Volumn 15, Issue 3, 2000, Pages 323-330

  Achiron, A ^a,b   Mor, F ^b   Margalit, R ^b   Cohen, I R ^b   Lider, O ^b   Miron, S ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Autoimmunity; Encephalitogenic T cells; Experimental autoimmune encephalomyelitis; Immunoglobulins

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

EID: 0033710645     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0433     Document Type: Article

References (30)

1. Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis
2. Clinical uses of intravenous immunoglobulins
3. Clinical use of intravenous immunoglobulins
4. Treatment of Guillain-Barre syndrome with high-dose gammaglobulin
5. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, crossover study
6. Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses
7. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group
8. Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis
9. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura
10. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use
11. Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg)
12. Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses
13. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ
14. Anti-cytokine nature of natural human immunoglobulin: One possible mechanism of the clinical effect of intravenous immunoglobulin therapy
15. Suppression of cytokine-dependent human T-cell proliferation by intravenous immunoglobulin
16. Cytokines and autoantibodies to cytokines
17. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: Process of selection of lines and characterization of the cells
18. Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion
19. T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins
20. Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases
21. Normal immunoglobulin G protects against experimental allergic encephalomyelitis by inducing transferable T cell unresponsiveness to myelin basic protein
22. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis
23. CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin 4-producing T helper cell type 2 subset
24. Lymphocyte Fc receptors: The special case of T cells
25. Lymphocyte Fc receptors: Expression, regulation and function
26. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: A novel mechanism of action of IVIg involving the Fas apoptotic pathway
27. Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with Staphylococcal superantigen
28. Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: A possible mechanism of action in vascular diseases
29. Down-regulation of lymphokine synthesis by intravenous gammaglobulin is dependent upon accessory cells
30. Mechanisms of action of intravenous immune globulin in immune-mediated diseases